#SmallBiotechsBigDecisions launches a new episode on early CRO engagement. Listen here: https://vist.ly/4axgv Dive into game-changing strategies to optimize funding, trial design, and patient recruitment. Discover how the right #CRO partnership can streamline clinical trials and reduce risk. ✔️ Watch the full episode: https://vist.ly/4axgv ✔️ Listen on the go: https://lnkd.in/gJwViHHV ✔️ Explore all episodes: https://vist.ly/4axgz ———— Follow Citeline, the leading provider of drug, device, company, clinical trial, and market intelligence in the pharmaceutical and medtech markets.
About us
Citeline is a leading global provider of data, analytics, and insights to the life sciences and pharmaceutical industries. With a focus on accelerating drug development and improving clinical outcomes, Citeline empowers organizations to make data-driven decisions at every stage of the drug lifecycle. We offer innovative solutions in clinical trial data, drug development intelligence, regulatory insights, and competitive intelligence. Our services help pharmaceutical companies, contract research organizations (CROs), and biotech firms reduce risks, optimize resources, and increase the success rate of clinical trials. Our unique blend of advanced technology, expert analysis, and industry expertise is what sets us apart. We utilize AI-powered tools, curated databases, and expert-led research to provide actionable intelligence that drives business decisions. Citeline’s core offerings include: ClinicalTrials.gov Data: Providing real-time access to comprehensive global clinical trial data, enabling faster, more informed decisions. Drug Development Intelligence: In-depth research and insights on drug pipelines, market opportunities, and competitive dynamics to enhance strategic planning. Regulatory Intelligence: Streamlined insights on regulatory requirements, approval processes, and compliance to ensure seamless product development and market entry. Competitive Intelligence: Actionable insights into the competitive landscape, helping organizations stay ahead of emerging trends, opportunities, and potential risks. With years of experience in serving top pharmaceutical companies and organizations worldwide, we have earned a reputation for delivering accurate, timely, and reliable data solutions. Our customers trust us to help them navigate the complexities of drug development and stay competitive in a fast-evolving market. At Citeline, we’re committed to innovation, excellence, and collaboration.
- Website
-
https://www.citeline.com/
External link for Citeline
- Industry
- Information Services
- Company size
- 501-1,000 employees
- Headquarters
- New York, New York
- Type
- Privately Held
Locations
-
Primary
Get directions
New York, New York, US
-
Get directions
London, City of London, GB
Employees at Citeline
Updates
-
ESMO 2025 is in full swing! Stay up to date with Scrip’s real-time reporting from Berlin. https://vist.ly/4avq3 Our editorial team is on the ground, delivering daily updates, exclusive interviews, and commercial impact analysis. Don’t miss a moment - sign up for your free trial and get all the news and analysis as it happens. 👉 https://vist.ly/4avq4 #ESMO2025 #ScripCoverage ESMO - European Society for Medical Oncology
-
Immerse yourself in the dynamic world of generics, biosimilars, and value-added medicines! Check out our infographic preview of Generics Bulletin’s Top 50 2025: https://vist.ly/4avpz ——— Ready to delve deeper? Follow Citeline for insightful analysis on pharma, biotech, medtech and consumer health. Download our app now: https://vist.ly/4avpw to stay updated.
-
-
Step into the future of obesity management with Dave Wallace, Generics Bulletin Executive Editor, as he illuminates life-changing generic alternatives of weight-loss medication in a recent Daily Mail - UK News piece. https://vist.ly/4ava7 (subscription required). #Semaglutide #Wegovy #Ozempic _____ Follow Citeline News & Insights for in-depth journalism and analysis of the pharma, biotech, medtech, and consumer health industries. Start your 7-day free trial today: https://vist.ly/4avaa
-
-
You bring the questions. We bring 500+ expert voices. https://vist.ly/4auiw | Discover how Ask the Analyst adds power to your expertise. With Ask the Analyst, Citeline subscribers get direct access to a network of over 500 industry experts in their fields: real people delivering clear, data-driven insights across regulatory shifts, clinical trials, R&D, market strategy, and more. • Tailored answers, delivered straight to your inbox within 72 hours • No bots. Just real experts who understand your world and speak your language. • Exclusive access for Citeline subscribers ———— Follow Citeline, the leading provider of drug, device, company, clinical trial, and market intelligence in the pharmaceutical and medtech markets.
-
-
HBW Insight's Over the Counter podcast takes you inside the conversations shaping consumer health: https://vist.ly/4atzm From regulatory changes to the strategies of industry leaders, each episode brings you timely insights and exclusive perspectives you won’t hear anywhere else. Stay ahead in health, beauty, and wellness with first-hand voices from the executives, associations, and innovators driving change. _____ Follow Citeline News & Insights for in-depth journalism and analysis of the pharma, biotech, medtech, and consumer health industries. Start your 7-day free trial today: https://vist.ly/4atzs
-
-
Citeline reposted this
One of my stories for the Pink Sheet from the RAPS mtg. What sponsors can do to account for the shrinking number of FDA advisory committee meetings. There are other ways to get the patient voice and other data in front of reviewers. Citeline https://lnkd.in/e-XDisFT
-
Download the infographic to preview the full editorial series: https://vist.ly/4as8e Get a visual snapshot of the companies shaping the global generics, biosimilars, and value-added medicines market. This exclusive infographic, powered by Generics Bulletin’s Top 50 2025 ranking, highlights: ✔️ Standout performers ✔️ Market shifts ✔️ Emerging players ——— Follow Citeline News & Insights for in-depth journalism and analysis of the pharma, biotech, medtech, and consumer health industries. Download the app today: https://vist.ly/4as8d
-
-
https://vist.ly/4arcf | Welcome to the new era of pipeline strategy: Pharmaprojects+ enhances the platform you trust with powerful new capabilities. From identifying similar drugs for competitive analysis to tracking development trends, every feature is designed to help you validate your strategy with confidence. With Pharmaprojects+ now you can: • Spot patterns by drug type, target, or company • Compare pipelines across disease areas and development stages • Use Ella, your AI chat assistant, to refine and validate faster Discover the new standard in pipeline strategy: https://vist.ly/4arcf ———— Follow Citeline, the leading provider of drug, device, company, clinical trial, and market intelligence in the pharmaceutical and medtech markets.
-